News for Sanofi Stock (SNY)

2 Bear Market Defying Stocks to Buy in May

The Motley Fool • 05/22/23

Sanofi: smoker's lung drug benefit was swift and sustained in trial

Reuters • 05/22/23

Press Release: Dupixent® (dupilumab) late-breaking Phase 3 COPD results presented at ATS and simultaneously published in the New England Journal of Medicine

GlobeNewsWire • 05/21/23

Sanofi Wins Supreme Court Patent Dispute With Amgen

WSJ • 05/18/23

Sanofi Applauds Supreme Court Ruling Supporting Scientific Innovation by Striking Down Amgen's Asserted PCSK9 Patent Claims in Amgen v Sanofi

PRNewsWire • 05/18/23

Sanofi Says Its RSV Shot Significantly Cut Hospitalization Risk In Newborns

Investors Business Daily • 05/12/23

Press Release: Nirsevimab delivers 83% reduction in RSV infant hospitalizations in a real-world clinical trial setting

GlobeNewsWire • 05/12/23

Prescription-drug costs in spotlight as pharmacy benefit reform advances in Senate

Market Watch • 05/11/23

7 Blue-Chip Stocks to Buy in May 2023

InvestorPlace • 05/04/23

Sanofi: COMBINED GENERAL MEETING OF MAY 25, 2023 - AVAILABILITY OF PREPARATORY DOCUMENTS

GlobeNewsWire • 05/04/23

SNY or LLY: Which Is the Better Value Stock Right Now?

Zacks Investment Research • 05/03/23

Flatiron Health Embarks on Strategic Collaboration with Sanofi to Make Clinical Trials More Efficient by Streamlining Data Acquisition at the Point of Care

Business Wire • 05/01/23

Maze Therapeutics Announces Exclusive Worldwide License Agreement with Sanofi for MZE001, an Oral Substrate Reduction Therapy for the Treatment of Pompe Disease

Business Wire • 05/01/23

Sanofi SA (SNY) Q1 2023 Earnings Call Transcript

Seeking Alpha • 04/27/23

Sanofi (SNY) Q1 Earnings Beat, Sales Miss, Dupixent Strong

Zacks Investment Research • 04/27/23

Press Release: Sanofi completes acquisition of Provention Bio, Inc.

GlobeNewsWire • 04/27/23

Sanofi backs guidance as it reports higher sales

Market Watch • 04/27/23

Is a Surprise Coming for Sanofi (SNY) This Earnings Season?

Zacks Investment Research • 04/26/23

Press Release: Hart-Scott-Rodino waiting period expires for Sanofi's acquisition of Provention Bio, Inc.

GlobeNewsWire • 04/26/23

4 Pharma, Biotech Stocks Poised to Beat Q1 Earnings Estimates

Zacks Investment Research • 04/24/23

Sanofi Announces Launch of AVAXIM® Junior in the UK for Active Immunisation Against Infection Caused by the Hepatitis A Virus in Children Aged 12 Months to 15 Years

Business Wire • 04/23/23

Sanofi (SNY) is a Great Momentum Stock: Should You Buy?

Zacks Investment Research • 04/21/23

Senate legislation would cap insulin at $35 per month for people with private insurance

CNBC • 04/21/23

Will Sanofi (SNY) Surpass Estimates This Earnings Season?

Zacks Investment Research • 04/20/23

4 Stocks Trading Near 52-Week High That Can Scale Higher

Zacks Investment Research • 04/19/23